“If the FDA accepts the panel’s findings, then the logical step would be for the agency to pull these drugs from the shelves of pharmacies and other outlets,” said Lawrence Gostin, a global health law professor at Georgetown University.
FDA panel says ingredient in popular oral decongestants is not effective
→
